2 of the best blue chip ASX shares to buy in April

ResMed Inc. (ASX:RMD) and this ASX blue chip share could be some of the best options for investors right now. Here’s why…
The post 2 of the best blue chip ASX shares to buy in April appeared first on The Motley Fool Australia. –

Arisrtocrat share price value and growth ASX shares

Have you got room for a blue chip or two in your portfolio? If you are, then take a look at the blockbuster blue chip shares listed below.

Here’s why they are highly rated:

ResMed Inc. (ASX: RMD)

The first blue chip share to look at is ResMed. It is one of the world’s leading medical device companies.

ResMed’s focus is primarily on the sleep treatment market and has a portfolio full of industry-leading solutions for sleep apnoea, insomnia, CPAP, and snoring. These products are available in more than 70 countries worldwide thanks to its direct offices and network of distributors.

Positively, the company invests heavily in its research and development, ensuring it stays ahead of the competition. Which certainly is a good thing given the size of the market. Management estimates that there are ~1 billion people suffering from sleep apnoea worldwide. However, the vast majority of these sufferers have yet to be diagnosed. This gives ResMed a significant runway for growth.

Morgans is positive on ResMed’s prospects. It recently retained its add rating and put a price target of $30.09 on its shares. The ResMed share price ended the week at $24.88.

Xero Limited (ASX: XRO)

Another blue chip ASX share to consider buying is Xero. It is a highly rated provider of a cloud-based business and accounting solution to small and medium sized businesses.

Like ResMed, Xero has a very large global market opportunity to grow into over the next decade. In addition to this, it has the opportunity to squeeze more and more revenue out of its users via its burgeoning app ecosystem.

It is due to this app ecosystem that Goldman Sachs believes Xero has a multi-decade runway for strong growth.

In light of this, it will come as no surprise to learn that the broker has a buy rating and $157.00 price target on its shares at present. This compares to the latest Xero share price of $127.20.

Where to invest $1,000 right now

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.

See The 5 Stocks

*Returns as of February 15th 2021

More reading

James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of Xero. The Motley Fool Australia has recommended ResMed Inc. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

The post 2 of the best blue chip ASX shares to buy in April appeared first on The Motley Fool Australia.

Trade The World Anywhere & Anytime!

Mobile app platform with over 50,000 global listed securities across 12 markets (over 70% global market capitalisation), right from your Android or iOS device.

Integrated with exclusive trading idea and investment analysis tools to help you find actionable insight on virtually every financial instrument across our 12 global markets, to help you optimise your trading strategies.

Refer Your Friends

Tell your friends about Monex and gift them FREE access to our trading tools.

We respect your privacy and will only send this one email notification to your friends. 

Share With Your Friends

Share on facebook
Share on twitter
Share on linkedin

Monex Trading Tools Access and Usage Terms

The Monex Trading Tools (referred to as ‘tools’ hereafter) are available to you inside your client portal;

To activate access to the tools, you must have a verified and approved trading account and have made a deposit of at least AUD $1000.

An active and funded account with a positive trading balance is required to continue to have access to the tools;

Although the tools are available to you indefinitely, Monex Securities may at it’s discretion disable access to the tools in the future;

Monex securities reserves the right to change these terms and conditions from time to time, as it sees fit, without notice.

Important Notice
iOS & Android App - 12 International Markets & Over 70% Global Market Cap. $0 Brokerage On US Trades. Click Here!